Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation (DiaBoLT2021)

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Enrolling

Conditions: Diabetes Mellitus Type 2; Liver Transplant

Study type: Observational

Funder types: Other

Identifiers

NCT06816303

DiaBoLT2021

Details and patient eligibility

About

observational study through which we aim to collect information on metabolic compensation, the degree of satisfaction with hypoglycemic therapy, the onset of complications of diabetes or liver disease, evaluation of survival, in patients on the list for at least three months or already undergoing liver transplantation for at least three months

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• type 2 diabetes mellitus
• presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months
• age ≥ 18 years
• signature of written informed consent to participate in the observational study, either by the participant or legal guardian

Exclusion criteria

• Pregnancy or breastfeeding